Controversies Over ‘Single-Multiple’ Drug Issue Reflects The Ignorance Regarding Basics Of Chemistry and Pharmacology
When you start perceiving potentized drugs in terms of diverse types of hydrosomes or ‘molecular imprints’ as the ‘active principles’ they contain, you will realize that all controversies over ‘monopharmacy/polypharmacy’ issue become totally irrelevant.
SIMILIMUM essentially means a drug substance that can provide the specific molecular imprints required to remove the particular molecular errors that caused the particular disease condition in the particular patient.
Since ‘multiple’ molecular errors exist in any patient in a particular point of time, expressed through ‘multiple’ groups of symptoms, he will inevitably need ‘multiple’ molecular imprints to remove them. If potentized form of a ‘single’ medicinal substance can provide all those ‘multiple’ molecular imprints, that ‘single’ drug substance will be enough. If we could not find a ‘single’ drug substance that contain ‘all’ the ‘multiple’ molecular imprints required by the patient as indicated by the ‘symptom groups’, we will have to include ‘multiple’ drug substances in our prescription. It is the constituent molecular imprints contained in our particular prescription that matter.
Important point is, we have to ensure that our prescription supplies ALL the diverse types of molecular imprints required to deactivate all the diverse types of pathogenic molecules working in the patient, as indicated by the diverse groups of subjective and objective symptoms expressed by him. If we could find a SINGLE drug preparation that could supply all the molecular imprints required by the patient I am dealing with, we can use that SINGLE drug preparation only. If we do not find such a single drug, we have to include as many number of drug preparations as required, in order to provide all the molecular imprints needed to remove all the molecular errors in the patient.
SINGLE/MULTIPLE drug controversy never bothers if we understand this scientific approach proposed by MIT, as we start thinking in terms of molecular imprints- not drug names. Actually, a drug become ‘single’, if it contains ‘single’ type of molecular imprints only. IF a drug contains more than one type of molecular imprints, it is a COMPOUND DRUG, even if it is known by a ‘single’ drug name, prepared from a ‘single’ SOURCE material, kept in a ‘single’ bottle, consumed as a ‘single’ unit for ‘drug proving’, or considered by ‘masters’ as ‘single’ drug.
When we consume NUX VOMICA Q, it is absorbed into the blood as various individual chemical molecules contained in it. It is these individual chemical molecules that interact with various biological molecules. Different molecules act up on different biological targets according to the molecular affinities of their functional groups. Biological molecules are inhibited, resulting in errors in the biochemical pathways mediated by those biological molecules. Such molecular level errors in biological processes cascades into a series of molecular errors, which are expressed through various groups of subjective and objective symptoms.
It is obvious that what we consider as the SYMPTOMS OF NUX VOMICA are actually the sum total of different SYMPTOM GROUPS, representing entirely different molecular errors produced in entirely different biological molecules, by the actions of entirely different chemical molecules contained in NUX VOMICA TINCTURE.
We have to remember, there is no such a thing called nux vomica molecule- only individual chemical molecules contained in nux vomica tincture. Each constituent molecule has its own specific chemical structure and properties. They act on different biological targets by this chemical properties.
Each individual chemical molecule contained in nux vomica acts as an individual drug. That means, NUX VOMICA is not a SINGLE drug, but a COMPOUND drug.
Homeopaths may find it difficult to accept this fact, as it contradicts with their beliefs as well as the lessons they are taught. But it is the scientific fact.
From scientific point of view of pharmaceutical chemistry, a DRUG is a biologically active unit contained in a substance used as therapeutic agent.
IT is the structure and properties of that chemical molecule that decides its medicinal properties and therapeutic actions. If such as substance contains only ONE type of biologically active unit, it is a SINGLE drug. If it contains different types of biologically active units, it is a COMPOUND drug.
It is obvious that most of the drugs we use in homeopathy – especially drugs of biological origin and complex minerals- contain diverse types of biologically active units, and hence they cannot be considered SINGLE drugs.
Molecular imprinting happens as individual molecules, and as such, potentized drugs prepared from a SINGLE drug substance will contain diverse types of molecular imprints representing the diverse types of individual constituent molecules contained in the substance. Those molecular imprints also act as individual units when applied in the organism. Hence, potentized drugs prepared by using a complex, seemingly single drug substance is actually a COMPOUND drug, containing diverse types of biologically active units, or ‘MOLECULAR IMPRINTS’.
IF you still cannot realize the meaninglessness and utter folly involved in talking about SINGLE DRUGS, it is the blindness caused by your dogmatic learning and lack of scientific awareness. I cannot help you for that!
- Posted in: Homeopathy Articles